Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using Electrical Impedance Tomography to Optimize Ventilator Settings in Patients with Severe Breathing Problems

Official title: Using Electrical Impedance Tomography-Guided Ventilator Settings to Reduce Mechanical Power in Acute Hypoxemic Respiratory Failure : An Exploratory Study

Run by Mahidol University · NCT06936618 · Data updated 2026-11-12

This study is trying to see if using a special imaging technique can help set ventilators better for patients with severe breathing problems like acute respiratory failure.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment17 (estimated)
SponsorMahidol University
Academic / other
Locations1 site (Bangkok)
StatusRecruiting
StartedDecember 17, 2024
Main results expectedOctober 2026
Study endsDecember 2026
Registry record updatedApril 27, 2025
Trial IDNCT06936618 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older diagnosed with acute hypoxemic respiratory failure who are expected to require invasive mechanical ventilation for at least 48 hours.

Probably not a fit

Patients with contraindications to EIT, severe obesity, or unstable cardiac conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This exploratory study investigates how Electrical Impedance Tomography (EIT) can guide ventilator settings to improve mechanical power in patients suffering from acute hypoxemic respiratory failure (AHRF), including those with Acute Respiratory Distress Syndrome (ARDS). The study will enroll 17 patients requiring invasive mechanical ventilation and will utilize a standardized EIT-guided PEEP titration protocol to determine optimal ventilator settings. Key parameters such as lung mechanics, gas exchange, and safety outcomes will be assessed before and after the intervention. Patients will be monitored for up to 28 days to evaluate the impact on mechanical ventilation duration and overall outcomes.

Why it matters

Potential benefit: If successful, this approach could lead to improved ventilation strategies that reduce the risk of ventilator-induced lung injury in critically ill patients.

How similar studies have gone: While the use of EIT in ventilator management is a relatively novel approach, preliminary studies have shown promising results in optimizing ventilator settings.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* Diagnosed with acute hypoxemic respiratory failure within 48 hours
* Expected to require invasive mechanical ventilation ≥ 48 hours
* On mechanical ventilation within 24 hours
* Deep sedation and neuromuscular blockade

Exclusion Criteria:

* Pregnancy
* Body mass index (BMI) \> 40 kg/m2
* Contraindications to using electrical impedance tomography, including
* Presence of a pacemaker or automatic implantable cardioverter-defibrillator (AICD)
* Inability to place the belt due to presence of surgical wounds dressing, thoracic or spinal cord trauma, recent thoracic surgery, etc.
* High risk for PEEP titration
* Hemodynamic instability defined as mean arterial pressure \< 65 mmHg despite optimization of fluid status and/or use of vasopressors
* Unstable cardiac arrhythmias
* Presence of lung bullae greater than 2 cm in diameter, identified on chest X-ray
* Presence of pneumothorax or pneumomediastinum
* Right-sided heart failure or severe pulmonary hypertension
* Neurologic conditions associated with a risk of intracranial hypertension
* Use of extracorporeal membrane oxygenation (ECMO)
* Severe chronic respiratory disease, defined as follows: requiring home oxygen therapy, or previous lung function showing (FEV1 less than 20 ml/kg PBW, or FEV1/FVC less than 50% predicted value), or chronic hypercapnia (PaCO2 greater than 45 mmHg) and/or chronic hypoxemia (PaO2 less than 55 mmHg) on FIO2 = 0.21, or radiographic x-ray evidence of any chronic over-inflation or chronic interstitial infiltration, or chronic restrictive, obstructive, neuromuscular, chest wall or pulmonary vascular disease resulting in severe exercise restriction (unable to climb stairs or perform household duties, secondary polycythemia, severe pulmonary hypertension with mean pulmonary arterial pressure greater than 40 mmHg)
* Decision to withhold life-sustaining treatment or palliative care.
* Moribund status with an expected survival of less than 24 hours.
* Refusal to provide informed consent

Where it's running

  • Siriraj Hospital, Mahidol University
    Bangkok, Thailand
    Recruiting

Study contacts

  • Principal investigator: Ranistha Ratanarat, Associated Professor, MD — Siriraj Hospital
  • Study coordinator: Jitanong Sootlek, MD, PCCM
  • Email: jitanong9651@gmail.com
  • Phone: +66954164563

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.